Literature DB >> 28988114

Regulatory effects of the AMPKα-SIRT1 molecular pathway on insulin resistance in PCOS mice: An in vitro and in vivo study.

Xin Tao1, Lei Chen2, Lisi Cai2, Shuqi Ge3, Xuanying Deng2.   

Abstract

In order to preliminarily explore the correlation between the AMPKα-SIRT1 pathway and insulin resistance and reproductive function in PCOS mice and find the pathogenesis molecular mechanism and potential therapeutic target of PCOS, we carried out in vitro study of human granulosa KGN cells and in vivo study of PCOS mouse model which was constructed with DHEA, and AICAR and Compound C were applied. We have found that SIRT1 and AMPKα expression in KGN cells gradually decreased as DHEA concentration increased; Mice of the PCOS model were in an obvious status of IR (P < 0.05). Granulosa cells in their ovarian were present in fewer numbers and were disorderly arranged, their numbers of immature follicles were significantly increased, and their AMPKα-SIRT1 pathways were down-regulated. The AMPKα-SIRT1 pathway could be up-regulated after AICAR treatment, resulting in improved IR status (P < 0.0001); however, the abovementioned effect was blocked by Compound C. Thus we concluded that the AMPKα-SIRT1 molecular pathway may be a molecular mechanism of IR in PCOS and may serve as a therapeutic target for the development of potential treatments for improving metabolic and reproductive function in PCOS.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPKα-SIRT1 molecular pathway; Insulin resistance; Mice; PCOS

Mesh:

Substances:

Year:  2017        PMID: 28988114     DOI: 10.1016/j.bbrc.2017.09.154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?

Authors:  Moein Ala; Mahan Ala
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-01

2.  Serum dipeptidyl peptidase-4 activity and progranulin level in polycystic ovary syndrome patients.

Authors:  Maryam Abolghasemi; Soleiman Mahjoub; Sedighe Esmaeilzadeh
Journal:  Caspian J Intern Med       Date:  2022

Review 3.  Sestrin2 in cancer: a foe or a friend?

Authors:  Moein Ala
Journal:  Biomark Res       Date:  2022-05-08

Review 4.  The role of Sirtuin 1 in the pathophysiology of polycystic ovary syndrome.

Authors:  Mali Wu; Jie Zhang; Ran Gu; Fangfang Dai; Dongyong Yang; Yajing Zheng; Wei Tan; Yifan Jia; Bingshu Li; Yanxiang Cheng
Journal:  Eur J Med Res       Date:  2022-08-27       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.